{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:33:30Z","timestamp":1789842810272,"version":"4.0.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"DOI":"10.7759\/cureus.77448","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:58:53Z","timestamp":1736909933000},"source":"Crossref","is-referenced-by-count":1,"title":["Exacerbation of Cerebellar Symptoms in Spinocerebellar Ataxia Induced by Lamotrigine: A Case Report"],"prefix":"10.7759","author":[{"given":"Koji","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9076-4","article-title":"Spinocerebellar ataxia: an update","volume":"266","author":"Sullivan R","year":"2019","unstructured":"Sullivan R, Yau WY, O'Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019, 266:533-44. 10.1007\/s00415-018-9076-4","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano L","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014, 42:174-83. 10.1159\/000358801","journal-title":"Neuroepidemiology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-024-01331-4","article-title":"Cognitive, emotional, and other non-motor symptoms of spinocerebellar ataxias","volume":"24","author":"Lin CR","year":"2024","unstructured":"Lin CR, Kuo SH, Opal P. Cognitive, emotional, and other non-motor symptoms of spinocerebellar ataxias. Curr Neurol Neurosci Rep. 2024, 24:47-54. 10.1007\/s11910-024-01331-4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363190-00009","article-title":"Lamotrigine: a review of its use in bipolar disorder","volume":"63","author":"Goldsmith DR","year":"2003","unstructured":"Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine: a review of its use in bipolar disorder. Drugs. 2003, 63:2029-50. 10.2165\/00003495-200363190-00009","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00405.x","article-title":"Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy","volume":"111","author":"Liu CS","year":"2005","unstructured":"Liu CS, Hsu HM, Cheng WL, Hsieh M. Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy. Acta Neurol Scand. 2005, 111:385-90. 10.1111\/j.1600-0404.2005.00405.x","journal-title":"Acta Neurol Scand"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1111\/cen3.12772","article-title":"Expanding clinical spectrum from Hashimoto's encephalopathy to anti-NAE antibody-associated disorders (NAEAD)","volume":"15","author":"Matsunaga A","year":"2024","unstructured":"Matsunaga A, Ikawa M, Yoneda M. Expanding clinical spectrum from Hashimoto's encephalopathy to anti-NAE antibody-associated disorders (NAEAD). Clin Exp Neuroimmunol. 2024, 15:24-31.","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.333440","article-title":"Lamotrigine-associated movement disorder: a literature review","volume":"69","author":"Rissardo JP","year":"2021","unstructured":"Rissardo JP, Fornari Caprara AL. Lamotrigine-associated movement disorder: a literature review. Neurol India. 2021, 69:1524-38. 10.4103\/0028-3886.333440","journal-title":"Neurol India"},{"key":"ref8","article-title":"Report of severe menorrhagia following the maximum amount of lamotrigine overdose","volume":"14","author":"Hajiali F","year":"2015","unstructured":"Hajiali F, Nassiri-Asl M. Report of severe menorrhagia following the maximum amount of lamotrigine overdose. Iran J Pharm Res. 2015, 14:1289-93.","journal-title":"Iran J Pharm Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/S1676-26492007000400008","article-title":"Late side-effects of valproate and lamotrigine","volume":"13","author":"Moreira B","year":"2007","unstructured":"Moreira B, Thom\u00e9-Souza S, Valente K. Late side-effects of valproate and lamotrigine. J Epilepsy Clin Neurophysiol. 2007, 13:187-9. 10.1590\/S1676-26492007000400008","journal-title":"J Epilepsy Clin Neurophysiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b23-00608","article-title":"Time-course changes in lamotrigine concentration after addition of valproate and the safety and long-term tolerability of lamotrigine-valproate combination therapy","volume":"47","author":"Yamamoto Y","year":"2024","unstructured":"Yamamoto Y, Usui N, Kagawa Y, Imai K. Time-course changes in lamotrigine concentration after addition of valproate and the safety and long-term tolerability of lamotrigine-valproate combination therapy. Biol Pharm Bull. 2024, 47:43-8. 10.1248\/bpb.b23-00608","journal-title":"Biol Pharm Bull"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial","volume":"53","author":"Kremer B","year":"1999","unstructured":"Kremer B, Clark CM, Almqvist EW, et al.. Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology. 1999, 53:1000-11. 10.1212\/wnl.53.5.1000","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335498-exacerbation-of-cerebellar-symptoms-in-spinocerebellar-ataxia-induced-by-lamotrigine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:58:55Z","timestamp":1736909935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335498-exacerbation-of-cerebellar-symptoms-in-spinocerebellar-ataxia-induced-by-lamotrigine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.77448","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}